Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A very rare syndromic disorder characterized by the variable triad of characteristic yellow nails, chronic respiratory manifestations, and primary lymphedema.
Features include: Slow-growing nails, Predominantly lower limb lymphedema, Yellow nails, and Hypoplasia of lymphatic vessels and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 4 | Slow-growing nails, Predominantly lower limb lymphedema, Yellow nails |
CELSR1 encodes cadherin EGF LAG seven-pass G-type receptor 1 (3,014 aa). Receptor that may have an important role in cell/cell signaling during nervous system formation Highest expression in Esophagus Mucosa (24.1 TPM) and Skin Not Sun Exposed Suprapubic (23.7 TPM).
Yellow nail syndrome is associated with mutations in the CELSR1 gene on chromosome 22.
The CELSR1 protein participates in SCRIB is required for asymmetric membrane localization of VANGL2 pathway.
CELSR1 is classified as a druggable target (Druggable Genome, G Protein Coupled Receptor, and Transporter categories) with score 0.0.
Genetic testing for CELSR1 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for yellow nail syndrome.
30 publications have been identified in PubMed for yellow nail syndrome. Research spans Case Report / Case Series (73%), Review / Meta-Analysis (10%), and Clinical Trial Publication (7%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 22 | 73% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:05 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Predominantly lower limb lymphedema |
3 |
10% |
Clinical study results | 2 | 7% |
Disease patterns and progression | 2 | 7% |
Laboratory research | 1 | 3% |
Gupta AK (2026). [PMID: 42003048](https://pubmed.ncbi.nlm.nih.gov/42003048/). *J Cosmet Dermatol*. [Review / Meta-Analysis]
Wang Y (2026). [PMID: 41724955](https://pubmed.ncbi.nlm.nih.gov/41724955/). *BMC pulmonary medicine*. [Epidemiology / Natural History]
Del Rio V (2026). [PMID: 42153051](https://pubmed.ncbi.nlm.nih.gov/42153051/). *Cureus*. [Case Report / Case Series]
Vargo SG (2026). [PMID: 41185095](https://pubmed.ncbi.nlm.nih.gov/41185095/). *Prenatal diagnosis*. [Epidemiology / Natural History]
Shamsuzzaman M (2026). [PMID: 41646558](https://pubmed.ncbi.nlm.nih.gov/41646558/). *Cureus*. [Case Report / Case Series]
Oba S (2025). [PMID: 39828623](https://pubmed.ncbi.nlm.nih.gov/39828623/). *Arthritis & rheumatology (Hoboken, N.J.)*. [Case Report / Case Series]
Canova TJ (2025). [PMID: 41043926](https://pubmed.ncbi.nlm.nih.gov/41043926/). *JACC. Case reports*. [Case Report / Case Series]
Di D (2025). [PMID: 41239673](https://pubmed.ncbi.nlm.nih.gov/41239673/). *Medicine*. [Case Report / Case Series]
Genrinho I (2025). [PMID: 41341356](https://pubmed.ncbi.nlm.nih.gov/41341356/). *Cureus*. [Case Report / Case Series]
Rahemtulla K (2025). [PMID: 39315922](https://pubmed.ncbi.nlm.nih.gov/39315922/). *Journal of palliative medicine*. [Case Report / Case Series]
AI-curated news mentioning yellow nail syndrome
Updated Jul 26, 2026
Recent research highlights the characteristics and implications of yellow nail syndrome, a rare condition that affects nail growth and appearance. The study provides insights into potential underlying mechanisms and associated symptoms.